#ESMO

Last 24h 📈 Bullish 📈1 📊1

Last 7 Days 📈 Bullish 📈1 📊1

Last 30 Days 📈 Bullish 📈1 📊1

Release 📈 Stocks

Eli Lilly Reports Positive Phase Data for Olomorasib in NSCLC Treatment

October 25, 2026 (just now)

Eli Lilly's olomorasib shows clinical promise in first-line NSCLC treatment, potentially bolstering the company's oncology pipeline following positive ESMO data.

LLY

🌍 AMERICAS Read More →

Release 📈 Stocks

Innovent Biologics Presents Phase 1 Data for IBI3001 at ESMO Congress

October 25, 2026 (49 minutes ago)

Innovent Biologics shares Phase 1 clinical trial results for IBI3001 at the ESMO congress, marking a key milestone in the company's oncology…

01801.HK

🌍 ASIA Read More →